These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 24786312)
1. Signal-regulatory protein α from the NOD mouse binds human CD47 with an exceptionally high affinity-- implications for engraftment of human cells. Kwong LS; Brown MH; Barclay AN; Hatherley D Immunology; 2014 Sep; 143(1):61-7. PubMed ID: 24786312 [TBL] [Abstract][Full Text] [Related]
2. Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Legrand N; Huntington ND; Nagasawa M; Bakker AQ; Schotte R; Strick-Marchand H; de Geus SJ; Pouw SM; Böhne M; Voordouw A; Weijer K; Di Santo JP; Spits H Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13224-9. PubMed ID: 21788504 [TBL] [Abstract][Full Text] [Related]
3. The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment. Iwamoto C; Takenaka K; Urata S; Yamauchi T; Shima T; Kuriyama T; Daitoku S; Saito Y; Miyamoto T; Iwasaki H; Kitabayashi I; Itoh K; Kishimoto J; Kohda D; Matozaki T; Akashi K Exp Hematol; 2014 Mar; 42(3):163-171.e1. PubMed ID: 24269920 [TBL] [Abstract][Full Text] [Related]
4. Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47. Wang C; Wang H; Ide K; Wang Y; Van Rooijen N; Ohdan H; Yang YG Cell Transplant; 2011; 20(11-12):1915-20. PubMed ID: 21535911 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the human inhibitory signal-regulatory protein α do not affect binding to its ligand CD47. Hatherley D; Lea SM; Johnson S; Barclay AN J Biol Chem; 2014 Apr; 289(14):10024-8. PubMed ID: 24550402 [TBL] [Abstract][Full Text] [Related]
6. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis. Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251 [TBL] [Abstract][Full Text] [Related]
7. Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. Theocharides AP; Jin L; Cheng PY; Prasolava TK; Malko AV; Ho JM; Poeppl AG; van Rooijen N; Minden MD; Danska JS; Dick JE; Wang JC J Exp Med; 2012 Sep; 209(10):1883-99. PubMed ID: 22945919 [TBL] [Abstract][Full Text] [Related]
8. Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation. Tena A; Kurtz J; Leonard DA; Dobrinsky JR; Terlouw SL; Mtango N; Verstegen J; Germana S; Mallard C; Arn JS; Sachs DH; Hawley RJ Am J Transplant; 2014 Dec; 14(12):2713-22. PubMed ID: 25278264 [TBL] [Abstract][Full Text] [Related]
9. Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. Yamauchi T; Takenaka K; Urata S; Shima T; Kikushige Y; Tokuyama T; Iwamoto C; Nishihara M; Iwasaki H; Miyamoto T; Honma N; Nakao M; Matozaki T; Akashi K Blood; 2013 Feb; 121(8):1316-25. PubMed ID: 23293079 [TBL] [Abstract][Full Text] [Related]
10. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target. Barclay AN; Van den Berg TK Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Wang H; VerHalen J; Madariaga ML; Xiang S; Wang S; Lan P; Oldenborg PA; Sykes M; Yang YG Blood; 2007 Jan; 109(2):836-42. PubMed ID: 17008545 [TBL] [Abstract][Full Text] [Related]
12. CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction. Zhao XW; van Beek EM; Schornagel K; Van der Maaden H; Van Houdt M; Otten MA; Finetti P; Van Egmond M; Matozaki T; Kraal G; Birnbaum D; van Elsas A; Kuijpers TW; Bertucci F; van den Berg TK Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18342-7. PubMed ID: 22042861 [TBL] [Abstract][Full Text] [Related]
13. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis. Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180 [TBL] [Abstract][Full Text] [Related]
14. The SIRPα-CD47 immune checkpoint in NK cells. Deuse T; Hu X; Agbor-Enoh S; Jang MK; Alawi M; Saygi C; Gravina A; Tediashvili G; Nguyen VQ; Liu Y; Valantine H; Lanier LL; Schrepfer S J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33416832 [TBL] [Abstract][Full Text] [Related]
15. Surfactant protein D (Sp-D) binds to membrane-proximal domain (D3) of signal regulatory protein α (SIRPα), a site distant from binding domain of CD47, while also binding to analogous region on signal regulatory protein β (SIRPβ). Fournier B; Andargachew R; Robin AZ; Laur O; Voelker DR; Lee WY; Weber D; Parkos CA J Biol Chem; 2012 Jun; 287(23):19386-98. PubMed ID: 22511785 [TBL] [Abstract][Full Text] [Related]
16. An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity. Wang X; Wang Y; Hu J; Xu H Cancer Med; 2021 Mar; 10(6):2125-2136. PubMed ID: 33629544 [TBL] [Abstract][Full Text] [Related]
17. The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages. Jung SH; Hwang JH; Kim SE; Young Kyu K; Park HC; Lee HT Xenotransplantation; 2017 May; 24(3):. PubMed ID: 28393401 [TBL] [Abstract][Full Text] [Related]
18. Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling. Koskinen C; Persson E; Baldock P; Stenberg Å; Boström I; Matozaki T; Oldenborg PA; Lundberg P J Biol Chem; 2013 Oct; 288(41):29333-44. PubMed ID: 23990469 [TBL] [Abstract][Full Text] [Related]
19. CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo. Ayi K; Lu Z; Serghides L; Ho JM; Finney C; Wang JCY; Liles WC; Kain KC Infect Immun; 2016 Jul; 84(7):2002-2011. PubMed ID: 27091932 [TBL] [Abstract][Full Text] [Related]
20. Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy. Hazama D; Yin Y; Murata Y; Matsuda M; Okamoto T; Tanaka D; Terasaka N; Zhao J; Sakamoto M; Kakuchi Y; Saito Y; Kotani T; Nishimura Y; Nakagawa A; Suga H; Matozaki T Cell Chem Biol; 2020 Sep; 27(9):1181-1191.e7. PubMed ID: 32640189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]